A retrospective series of long-term survivors of metastatic breast cancer in complete remission

被引:7
作者
Amoroso, V
Valcamonico, F
Simoncini, E
Ardighieri, L
Grisanti, S
Vassalli, L
Marpicati, P
Lucini, L
Ferrari, VD
Rangoni, G
Marini, G
机构
[1] Azienda Spedali Civili, Unita Operat Oncol Med, IT-25123 Brescia, Italy
[2] Azienda Spedali Civili, Fdn Beretta, IT-25123 Brescia, Italy
关键词
breast cancer; chemotherapy; metastatic breast cancer; multidisciplinary treatments; survival;
D O I
10.1159/000084819
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To describe clinical features, treatment modalities and long-term outcome of patients with overt metastatic breast cancer in complete remission for more than 5 years. Patients and Methods: A retrospective survey of 12 patients who were referred to a single institution from 1982 to 1995. Results: The majority of the long-term survivors had a good performance status, endocrine-responsive disease and a single metastatic site. Ten patients had received chemotherapy, 8 patients hormone therapy, and 2 patients had been treated with surgery followed by systemic therapies. At a median follow-up of 11.7 years, 10 of the 12 patients were still in complete remission. The median duration of complete remission was 9.2 years ( range 5.0 - 15.7 years). Conclusions: This case series confirms that only a few metastatic breast cancer patients could potentially be cured with multidisciplinary treatments. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:48 / 51
页数:4
相关论文
共 15 条
[1]  
Bruzzi P, 2002, ANN NY ACAD SCI, V963, P144
[2]   Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy [J].
Castiglione-Gertsch, M ;
Tattersall, M ;
Hacking, A ;
Goldhirsch, A ;
Gudgeon, A ;
Gelber, RD ;
Lindtner, J ;
Coates, A ;
Collins, J ;
Isley, M ;
Senn, HJ ;
Rudenstam, CM .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (14) :2321-2325
[3]   Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer [J].
Greenberg, PAC ;
Hortobagyi, GN ;
Smith, TL ;
Ziegler, LD ;
Frye, DK ;
Buzdar, AU .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (08) :2197-2205
[4]   Can we cure limited metastatic breast cancer? [J].
Hortobagyi, GN .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :620-623
[5]   Drug therapy - Treatment of breast cancer [J].
Hortobagyi, GN .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (14) :974-984
[6]   THE INFLUENCE OF ADJUVANT CHEMOTHERAPY ON OUTCOME AFTER RELAPSE FOR PATIENTS WITH BREAST-CANCER [J].
HOUSTON, SJ ;
RICHARDS, MA ;
BENTLEY, AE ;
SMITH, P ;
RUBENS, RD .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (11) :1513-1518
[7]   Is patient travel distance associated with survival on phase II clinical trials in oncology? [J].
Lamont, EB ;
Hayreh, D ;
Pickett, KE ;
Dignam, JJ ;
List, MA ;
Stenson, KM ;
Haraf, DJ ;
Brockstein, BE ;
Sellergren, SA ;
Vokes, EE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (18) :1370-1375
[8]   5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID AS SALVAGE TREATMENT OF ADVANCED BREAST-CANCER - AN UPDATE [J].
MARINI, G ;
SIMONCINI, E ;
ZANIBONI, A ;
GORNI, F ;
MARPICATI, P ;
ZAMBRUNI, A .
ONCOLOGY, 1987, 44 (06) :336-340
[9]   COMPLETE REMISSION FOLLOWING ENDOCRINE OR COMBINED CYTOTOXIC AND HORMONAL TREATMENT IN ADVANCED BREAST-CANCER - A RETROSPECTIVE ANALYSIS [J].
PEDRAZZINI, A ;
CAVALLI, F ;
BRUNNER, KW ;
GOLDHIRSCH, A ;
MERMILLOD, B .
ONCOLOGY, 1987, 44 (01) :51-59
[10]   Revision of the American Joint Committee on Cancer staging system for breast cancer [J].
Singletary, SE ;
Allred, C ;
Ashley, P ;
Bassett, LW ;
Berry, D ;
Bland, KI ;
Borgen, PI ;
Clark, CG ;
Edge, SB ;
Hayes, DF ;
Hughes, LL ;
Hutter, RVP ;
Morrow, M ;
Page, DL ;
Recht, A ;
Theriault, RL ;
Thor, A ;
Weaver, DL ;
Wieand, HS ;
Greene, FL .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3628-3636